Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Search by expertise, name or affiliation
Panta rhei, also drug eluting stent technology
Mauro Chiarito,
Roxana Mehran
Icahn School of Medicine at Mount Sinai
Medicine
Medicine - Cardiology
Research output
:
Contribution to journal
›
Editorial
1
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Panta rhei, also drug eluting stent technology'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Drug-eluting Stent
100%
Panta Rhei
100%
Resolute Zotarolimus-eluting Stent
66%
Stent Thrombosis
33%
Low Dose Rate
33%
Stent Implantation
33%
Clinical Practice
33%
Repeat Revascularization
33%
Follow-up Data
33%
Single-arm Study
33%
Thin Struts
33%
Long-term Performance
33%
5-year Outcomes
33%
Durable Polymer
33%
Medicine and Dentistry
Drug-Eluting Stent
100%
Zotarolimus
66%
Observational Study
33%
Arm
33%
Stent Thrombosis
33%
Decision Making
33%
Revascularization
33%